Companies / Leica Biosystems / Aperio GT 450
Leica Biosystems

Aperio GT 450 | Leica Biosystems

Automated, High Capacity Digital Pathology Slide Scanner.

The Aperio GT 450 enables histotechnicians to complete scanning tasks quickly and with confidence leveraging a 32-second scan speed*. Output 81 slides/hr at 40x* delivering high quality images with Leica optics and with an IT architecture that is secure and scalable. From the pathology lab to the IT room, the Aperio GT 450 is designed to scale up digital pathology operations.

- Improve case turnaround with no touch during scanning and continuous loading of the racks directly from the HistoCore SPECTRA Workstation (Stainer & Coverslipper)
- Help increase IT security and control with a dedicated SAM (Scanner Admin Manager) server and software that allows you to set up and monitor multiple Aperio GT 450s at a time. No more single workstations for each scanner
- Ensure excellent image quality with Leica optics

*Scan speed assumes 15mm x 15mm area at 40x

Aperio is a trademark of the Leica Biosystems group of companies in the USA and optionally in other countries. GT and GT 450 are trademarks of Leica Biosystems Imaging, Inc. Other logos, product and/or company names might be trademarks of their respective owners.

FOR RESEARCH USE ONLY. Not For Use In Diagnostic Procedures.

Citations (1)


(1) Preanalytic variable effects on segmentation and quantification machine learning algorithms for amyloid-β analyses on digitized human brain slides.

Journal of neuropathology and experimental neurology
December 20, 2024
Oliveira LC, Lai Z, Harvey D, Nzenkue K, Jin LW, Decarli C, Chuah CN, Dugger BN

Computational machine learning (ML)-based frameworks could be advantageous for scalable analyses in neuropathology. A recent deep learning (DL) framework has shown promise in automating the processes of visualizing and quantifying different types of amyloid-β deposits as well as segmenting white matter (WM) from gray matter (GM) on digitized immunohistochemically stained slides. However, this framework has only been trained and evaluated on amyloid-β-stained slides with minimal changes in preanalytic variables. In this study, we evaluated select preanalytical variables including magnification, compression rate, and storage format using three digital slides scanners (Zeiss Axioscan Z1, Leica Aperio AT2, and Leica Aperio GT 450), on over 60 whole slide images, in a cohort of 14 cases having a spectrum of amyloid-β deposits. We conducted statistical comparisons of preanalytic variables with repeated measures analysis of variance evaluating the outputs of two DL frameworks for segmentation and object classification tasks. For both WM/GM segmentation and amyloid-β plaque classification tasks, there were statistical differences with respect to scanner types (p < 0.05) and magnifications (p < 0.05). Although small numbers of cases were analyzed, this pilot study highlights the significance of preanalytic variables that may alter the performance of ML algorithms.

Reviews


No reviews yet

ABOUT THE COMPANY

Leica Biosystems is a global leader in Anatomical Pathology solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides Pathologists, Histologists, and Researchers a comprehensive range of products for each step in the Pathology process. From specimen preparation and staining to imaging...

READ MORE